The selective COX-2 inhibitors are a new class of NSAIDs, such as etodolac (186) and indomethacin (187)
Risk stratification integrates non-modifiable factors (advanced age, African American/Hispanic/South Asian ethnicity, TCF7L2 polymorphisms, autosomal dominant polycystic kidney disease) with modifiable determinants (pre-transplant dysglycemia, obesity, hypomagnesemia, hepatitis C and cytomegalovirus infections, acute rejection, and diuretic use)
Answer: Tirzepatide is a once-weekly injectable medication that activates two gut hormone receptors, GLP-1 and GIP, to reduce appetite, slow stomach emptying, and support steady fat loss as part of a structured weight management plan
It is more commonly found in teenagers and young adults, particularly females, but anyone can be affected